CWD [CWD] vs Cyient DLM [CYIENTDLM] Detailed Stock Comparison
CWD
BSE
Loading...
Cyient DLM
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: CWD wins in 8 metrics, Cyient DLM wins in 9 metrics, with 0 ties. Cyient DLM appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CWD | Cyient DLM | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,121.53 | 54.46 | Cyient DLM |
| Price-to-Book Ratio | 11.00 | 3.72 | Cyient DLM |
| Debt-to-Equity Ratio | 14.80 | 31.73 | CWD |
| PEG Ratio | N/A | -1.82 | N/A |
| EV/EBITDA | 74.77 | 26.91 | Cyient DLM |
| Profit Margin (TTM) | 7.62% | 4.22% | CWD |
| Operating Margin (TTM) | 25.86% | 5.22% | CWD |
| EBITDA Margin (TTM) | 25.86% | 5.22% | CWD |
| Return on Equity | 6.17% | 7.17% | Cyient DLM |
| Return on Assets (TTM) | 5.16% | 4.02% | CWD |
| Free Cash Flow (TTM) | $-3.30M | $-1.12B | CWD |
| 1-Year Return | 64.46% | -44.35% | CWD |
| Price-to-Sales Ratio (TTM) | 21.54 | 2.30 | Cyient DLM |
| Enterprise Value | $6.23B | $37.61B | Cyient DLM |
| EV/Revenue Ratio | 18.94 | 2.44 | Cyient DLM |
| Gross Profit Margin (TTM) | N/A | 40.21% | N/A |
| Revenue per Share (TTM) | $87 | $194 | Cyient DLM |
| Earnings per Share (Diluted) | $1.44 | $8.18 | Cyient DLM |
| Beta (Stock Volatility) | -0.63 | -0.32 | CWD |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CWD vs Cyient DLM Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CWD | 1.00% | 7.75% | 8.39% | 84.63% | 70.00% | 102.38% |
| Cyient DLM | 0.73% | 4.19% | -7.37% | -6.88% | 6.50% | -33.79% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CWD | 64.46% | -4.76% | 796.72% | 796.72% | 796.72% | 796.72% |
| Cyient DLM | -44.35% | -11.25% | -11.25% | -11.25% | -11.25% | -11.25% |
Performance & Financial Health Analysis: CWD vs Cyient DLM
| Metric | CWD | CYIENTDLM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹7.09B | ₹35.35B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,220 | 91,925 |
| 90 Day Avg. Volume | 2,467 | 153,176 |
| Last Close | ₹1,615.00 | ₹445.45 |
| 52 Week Range | ₹590.00 - ₹1,650.00 | ₹378.60 - ₹840.80 |
| % from 52W High | -2.12% | -47.02% |
| All-Time High | ₹2,425.00 (Oct 31, 2022) | ₹883.80 (Feb 26, 2024) |
| % from All-Time High | -33.40% | -49.60% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.17% | 0.08% |
| Quarterly Earnings Growth | 0.18% | -0.30% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.04% |
| Operating Margin (TTM) | 0.26% | 0.05% |
| Return on Equity (TTM) | 0.06% | 0.07% |
| Debt to Equity (MRQ) | 14.80 | 31.73 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹146.80 | ₹119.72 |
| Cash per Share (MRQ) | ₹68.76 | ₹5.94 |
| Operating Cash Flow (TTM) | ₹27.46M | ₹180.85M |
| Levered Free Cash Flow (TTM) | ₹-66,763,624 | ₹680.76M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: CWD vs Cyient DLM
| Metric | CWD | CYIENTDLM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,121.53 | 54.46 |
| Forward P/E | N/A | 26.37 |
| PEG Ratio | N/A | -1.82 |
| Price to Sales (TTM) | 21.54 | 2.30 |
| Price to Book (MRQ) | 11.00 | 3.72 |
| Market Capitalization | ||
| Market Capitalization | ₹7.09B | ₹35.35B |
| Enterprise Value | ₹6.23B | ₹37.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 18.94 | 2.44 |
| Enterprise to EBITDA | 74.77 | 26.91 |
| Risk & Other Metrics | ||
| Beta | -0.63 | -0.32 |
| Book Value per Share (MRQ) | ₹146.80 | ₹119.72 |
Financial Statements Comparison: CWD vs Cyient DLM
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CWD | CYIENTDLM |
|---|---|---|
| Revenue/Sales | N/A | ₹2.78B |
| Cost of Goods Sold | N/A | ₹1.66B |
| Gross Profit | N/A | ₹1.12B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | ₹145.41M |
| EBITDA | N/A | ₹292.34M |
| Pre-Tax Income | N/A | ₹101.01M |
| Income Tax | N/A | ₹26.38M |
| Net Income (Profit) | N/A | ₹74.63M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CWD | CYIENTDLM |
|---|---|---|
| Cash & Equivalents | ₹272.60M | ₹471.17M |
| Total Current Assets | ₹679.97M | ₹12.82B |
| Total Current Liabilities | ₹218.33M | ₹5.34B |
| Long-Term Debt | ₹35.98M | ₹1.95B |
| Total Shareholders Equity | ₹583.51M | ₹9.49B |
| Retained Earnings | N/A | ₹2.26B |
| Property, Plant & Equipment | ₹39.28M | ₹324.61M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CWD | CYIENTDLM |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CWD | CYIENTDLM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,220 | 91,925 |
| Average Daily Volume (90 Day) | 2,467 | 153,176 |
| Shares Outstanding | 4.28M | 79.31M |
| Float Shares | 1.45M | 37.97M |
| % Held by Insiders | 0.73% | 0.61% |
| % Held by Institutions | 0.00% | 0.26% |
Dividend Analysis & Yield Comparison: CWD vs Cyient DLM
| Metric | CWD | CYIENTDLM |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |